Business Development
Solutions
Business Development & Licensing
Licensing deals to fund research and development, clinical operations, and market expansion are resource and cost intensive. IntraLinks Dealspace is a secure centralized repository that enables you to trim due diligence costs, reduce transaction times, control information, and accelerate future deals.
VISION AND PLATFORM
Maximize your business development and licensing efforts.
Pharmaceutical and biotech companies, strategic partnering divisions of contract research organizations (CROs), and investment firms are entering into alliances and joint ventures at an ever-increasing pace. Whether the target is a new drug, new capital, or strategic alignment, business development and licensing deals pump lifeblood into pharmaceutical and biotech companies of all sizes. As the rate of transactions increases, so does the number of hours and resources needed to conduct due diligence.
Life sciences professionals use IntraLinks Dealspace to raise capital, evaluate opportunities, expedite due diligence, manage alliances, and capture institutional knowledge. IntraLinks Dealspace will help you exchange critical information throughout the life of your business licensing and development deal with internal and external parties. Using IntraLinks Dealspace eliminates the hassles of trying to e-mail large files, only to have them bounce back or risk unauthorized and unsecure distribution. In addition IntraLinks Dealspace enables you to eliminate the costs, headaches, and the security risks of faxing, printing, and overnight mail delivery. Post deal, IntraLinks can be used to support alliance management, post-merger integration, and streamline the drug manufacturing process.
IntraLinks Dealspace facilitates the business development and licensing process by:
- Accelerating the due diligence process with a secure, auditable, central point of access and control for managing and distributing critical intellectual property
- Establishing a single place of record for critical documents to help manage version control
- Shaving weeks off of your deal and speeding it to close with automated workflows to ensure that information moves freely between parties throughout the life of the deal
- Facilitating the creation of repeatable processes and infrastructure for future deals
- Offering a greater degree of security for document exchange than offered by e-mail or FTP
- Establishing clear protocols to manage critical information and develop lucrative partnerships
- Allowing buyers to review documents in parallel, slashing time required for due diligence
- Providing insight into prospective buyers’ intentions and activities with reporting
- Securing documents, even at the endpoint with digital rights management capabilities
- Extending critical information to the largest possible universe of qualified investors in less time
RELATED WHITEPAPER
Safety Document Exchange in the Global Clinical Research Environment: Secure, Cost-effective, and Well-connected – Not long ago, the public assumed that drugs approved as safe and effective by the FDA were, in fact, safe and effective. But a series of highly publicized product withdrawals and black box warnings given to marketed drugs in recent years has alerted the public and Congress that the FDA must give greater scrutiny to safety signals arising during drug development. As a result, the proper and timely reporting of Serious Adverse Events (SAEs) during clinical trials is under scrutiny.
Case Studies
-
Business Development
-
Business Development
immatics biotechnologies
-
Business Development & Licensing
Reliant Pharmaceuticals